AAAAAA

   
Results: 1-11 |
Results: 11
GUIDELINES FOR DEPOT ANTIPSYCHOTIC TREATMENT IN SCHIZOPHRENIA
Authors: KANE JM AGUGLIA E ALTAMURA AC GUTIERREZ JLA BRUNELLO N FLEISCHHACKER WW GAEBEL W GERLACH J GUELFI JD KISSLING W LAPIERRE YD LINDSTROM E MENDLEWICZ J RACAGNI G CARULLA LS SCHOOLER NR
Citation: Jm. Kane et al., GUIDELINES FOR DEPOT ANTIPSYCHOTIC TREATMENT IN SCHIZOPHRENIA, European neuropsychopharmacology, 8(1), 1998, pp. 55-66
RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA - RESULTS OF A STUDY OFPATIENTS FROM GERMANY, AUSTRIA, AND SWITZERLAND
Authors: MOLLER HJ BAUML J FERRERO F FUGER J GERETSEGGER C KASPER S KISSLING W SCHUBERT H
Citation: Hj. Moller et al., RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA - RESULTS OF A STUDY OFPATIENTS FROM GERMANY, AUSTRIA, AND SWITZERLAND, European archives of psychiatry and clinical neuroscience, 247(6), 1997, pp. 291-296
COMPLIANCE, QUALITY MANAGEMENT AND STANDARDS IN THE TREATMENT OF SCHIZOPHRENIA
Authors: KISSLING W
Citation: W. Kissling, COMPLIANCE, QUALITY MANAGEMENT AND STANDARDS IN THE TREATMENT OF SCHIZOPHRENIA, Neuropsychobiology, 35(2), 1997, pp. 70-72
PSYCHOEDUCATIONAL GROUPS AMONG SCHIZOPHRE NIC-PATIENTS - INFLUENCE ONKNOWLEDGE AND COMPLIANCE - RESULTS OF THE MUNICH PIP STUDY
Authors: BAUML J KISSLING W PITSCHELWALZ G
Citation: J. Bauml et al., PSYCHOEDUCATIONAL GROUPS AMONG SCHIZOPHRE NIC-PATIENTS - INFLUENCE ONKNOWLEDGE AND COMPLIANCE - RESULTS OF THE MUNICH PIP STUDY, Nervenheilkunde, 15(3), 1996, pp. 145-150
COMPLIANCE, QUALITY ASSURANCE AND STANDARDS FOR RELAPSE PREVENTION INSCHIZOPHRENIA (REPRINTED FROM ACTA PSYCHIATR SCAND, VOL 89, SUPPL 382, 1994)
Authors: KISSLING W
Citation: W. Kissling, COMPLIANCE, QUALITY ASSURANCE AND STANDARDS FOR RELAPSE PREVENTION INSCHIZOPHRENIA (REPRINTED FROM ACTA PSYCHIATR SCAND, VOL 89, SUPPL 382, 1994), Nordic journal of psychiatry, 49, 1995, pp. 7-15
A CONTROLLED-STUDY OF THE EFFICACY AND SAFETY OF MIANSERIN AND AMITRIPTYLINE IN DEPRESSIVE INPATIENTS
Authors: MOLLER HJ KASPER S MULLER H KISSLING W FUGER J RUHRMANN S
Citation: Hj. Moller et al., A CONTROLLED-STUDY OF THE EFFICACY AND SAFETY OF MIANSERIN AND AMITRIPTYLINE IN DEPRESSIVE INPATIENTS, Pharmacopsychiatry, 28(6), 1995, pp. 249-252
THE ROLE OF COMPLIANCE IN THE TREATMENT OF SCHIZOPHRENIA - PROCEEDINGS OF A LUNDBECK SYMPOSIUM, COPENHAGEN, DENMARK, NOVEMBER 12-13, 1993 -PREFACE
Authors: GJERRIS A KISSLING W
Citation: A. Gjerris et W. Kissling, THE ROLE OF COMPLIANCE IN THE TREATMENT OF SCHIZOPHRENIA - PROCEEDINGS OF A LUNDBECK SYMPOSIUM, COPENHAGEN, DENMARK, NOVEMBER 12-13, 1993 -PREFACE, Acta psychiatrica Scandinavica, 89, 1994, pp. 5-5
COMPLIANCE, QUALITY ASSURANCE AND STANDARDS FOR RELAPSE PREVENTION INSCHIZOPHRENIA
Authors: KISSLING W
Citation: W. Kissling, COMPLIANCE, QUALITY ASSURANCE AND STANDARDS FOR RELAPSE PREVENTION INSCHIZOPHRENIA, Acta psychiatrica Scandinavica, 89, 1994, pp. 16-24
THE ROLE OF COMPLIANCE IN THE TREATMENT OF SCHIZOPHRENIA - PROCEEDINGS OF A LUNDBECK SYMPOSIUM, COPENHAGEN, DENMARK, NOVEMBER 12-13, 1993 -CONCLUDING REMARKS
Authors: GJERRIS A KISSLING W
Citation: A. Gjerris et W. Kissling, THE ROLE OF COMPLIANCE IN THE TREATMENT OF SCHIZOPHRENIA - PROCEEDINGS OF A LUNDBECK SYMPOSIUM, COPENHAGEN, DENMARK, NOVEMBER 12-13, 1993 -CONCLUDING REMARKS, Acta psychiatrica Scandinavica, 89, 1994, pp. 93-93
DOUBLE-BLIND MULTICENTER STUDY OF PAROXETINE AND AMITRIPTYLINE IN DEPRESSED INPATIENTS
Authors: MOLLER HJ BERZEWSKI H ECKMANN F GONZALVES N KISSLING W KNORR W RESSLER P RUDOLF GAE STEINMEYER EM MAGYAR I SZUCS R SZILARD J
Citation: Hj. Moller et al., DOUBLE-BLIND MULTICENTER STUDY OF PAROXETINE AND AMITRIPTYLINE IN DEPRESSED INPATIENTS, Pharmacopsychiatry, 26(3), 1993, pp. 75-78
POLYUNSATURATED FATTY-ACIDS IN PEROXISOMAL DISORDERS - A HYPOTHESIS AND A PROPOSAL FOR TREATMENT
Authors: ROELS F FISCHER S KISSLING W
Citation: F. Roels et al., POLYUNSATURATED FATTY-ACIDS IN PEROXISOMAL DISORDERS - A HYPOTHESIS AND A PROPOSAL FOR TREATMENT, Journal of Neurology, Neurosurgery and Psychiatry, 56(8), 1993, pp. 937-937
Risultati: 1-11 |